MedTrace Logo

Field Trial of a Relapse Prevention Program for Adolescents Receiving Substance Use Treatment

NCT02125539 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2015-07-27

No results posted yet for this study

Summary

The purpose of this study is to provide a comprehensive evaluation of the new, Navigating my Journey program for adolescents receiving treatment in an outpatient substance abuse center.

The primary hypotheses are that, relative to the control condition, Navigating my Journey will be associated with significantly higher motivation, higher self-efficacy, improved relapse coping skills, and lower substance use. The secondary hypotheses are that, relative to the control condition, Navigating my Journey will be associated with increased therapeutic alliances with counselors.

Conditions

  • Substance-Related Disorders

Interventions

BEHAVIORAL

Navigating my Journey program

The online relapse prevention program called Navigating my Journey is designed for adolescents who are receiving outpatient treatment for substance abuse. Since the Navigating my Journey program will be available to adolescents 24/7, it is easy for them to access at their convenience. The program functions as an adjunct to treatment and is designed to complement and enhance the work the adolescent does with the counselor during counseling sessions. The core intervention is expected to last for 12 weeks.

BEHAVIORAL

Attention Control

Client participants in the control group will receive their typical course of counseling and a link to online online health information in PDF form as an attention control.

Sponsors & Collaborators

  • Inflexxion, Inc.

    lead INDUSTRY

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

Principal Investigators

  • Kimberlee Trudeau, Ph. D. · Inflexxion, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02125539 on ClinicalTrials.gov